HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stein, Z A Search for Related Content PubMed PubMed Citation Articles by Stein, Z A

HIV prevention: the need for methods women can use.

Z A Stein

HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, NY 10032.

Efforts to prevent heterosexual transmission of HIV (human immunodeficiency virus) infection have thus far focused on modifying sexual behaviors and the use of condoms. While the experience of family planners, particularly in those countries most threatened by heterosexual HIV transmission, has shown that the most effective measures of pregnancy prevention have relied on women, little attention has been given to barriers to HIV transmission that depend on the woman and are under her control. Tactics which interrupt transmission of the virus should be considered in their own right and separated from those that interrupt pregnancy, for insurance, the diaphragm. Greater emphasis is urged for research on preventive methods women could use, including the possibility of a topical virucide that might block transmission through the vaginal route.

This article has been cited by other articles:

				C. Lackman-Smith, C. Osterling, K. Luckenbaugh, M. Mankowski, B. Snyder, G. Lewis, J. Paull, A. Profy, R. G. Ptak, R. W. Buckheit Jr., et al. Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1768 - 1781. [Abstract] [Full Text] [PDF]

				J. E. Cummins Jr., J. Guarner, L. Flowers, P. C. Guenthner, J. Bartlett, T. Morken, L. A. Grohskopf, L. Paxton, and C. S. Dezzutti Preclinical Testing of Candidate Topical Microbicides for Anti-Human Immunodeficiency Virus Type 1 Activity and Tissue Toxicity in a Human Cervical Explant Culture Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1770 - 1779. [Abstract] [Full Text] [PDF]

				R. S. Aguiar, L. J. Costa, H. S. Pereira, R. M. Brindeiro, and A. Tanuri Development of a New Methodology for Screening of Human Immunodeficiency Virus Type 1 Microbicides Based on Real-Time PCR Quantification Antimicrob. Agents Chemother., February 1, 2007; 51(2): 638 - 644. [Abstract] [Full Text] [PDF]

				F Behets, A N. Turner, K Van Damme, N L Rabenja, N Ravelomanana, K Zeller, and J R Rasolofomanana Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar Sex Transm Inf, December 1, 2005; 81(6): 472 - 476. [Abstract] [Full Text] [PDF]

				A M Minnis and N S Padian Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions Sex Transm Inf, June 1, 2005; 81(3): 193 - 200. [Abstract] [Full Text] [PDF]

				L. Artz, M. Macaluso, J. Kelaghan, H. Austin, M. Fleenor, L. Robey, E. W. Hook III, and I. Brill An Intervention to Promote the Female Condom to Sexually Transmitted Disease Clinic Patients Behav Modif, March 1, 2005; 29(2): 318 - 369. [Abstract] [PDF]

				C. S. Dezzutti, V. N. James, A. Ramos, S. T. Sullivan, A. Siddig, T. J. Bush, L. A. Grohskopf, L. Paxton, S. Subbarao, and C. E. Hart In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 Transmission Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3834 - 3844. [Abstract] [Full Text] [PDF]

				Y. Van Herrewege, J. Michiels, J. Van Roey, K. Fransen, L. Kestens, J. Balzarini, P. Lewi, G. Vanham, and P. Janssen In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides Antimicrob. Agents Chemother., January 1, 2004; 48(1): 337 - 339. [Abstract] [Full Text] [PDF]

				F M Cowan Adolescent reproductive health interventions Sex Transm Inf, October 1, 2002; 78(5): 315 - 318. [Full Text]

				J. Piret, S. Roy, M. Gagnon, S. Landry, A. Desormeaux, R. F. Omar, and M. G. Bergeron Comparative Study of Mechanisms of Herpes Simplex Virus Inactivation by Sodium Lauryl Sulfate and n-Lauroylsarcosine Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2933 - 2942. [Abstract] [Full Text] [PDF]

				G. D. Smith and E. Susser Zena Stein, Mervyn Susser and epidemiology: observation, causation and action Int. J. Epidemiol., February 1, 2002; 31(1): 34 - 37. [Full Text] [PDF]

				I. Susser Health rights for women in the age of AIDS Int. J. Epidemiol., February 1, 2002; 31(1): 45 - 48. [Full Text] [PDF]

				N. Van Devanter, V. Gonzales, C. Merzel, N. S. Parikh, D. Celantano, and J. Greenberg Effect of an STD/HIV Behavioral Intervention on Women's Use of the Female Condom Am J Public Health, January 1, 2002; 92(1): 109 - 115. [Abstract] [Full Text] [PDF]

				J. Bestman-Smith, J. Piret, A. Desormeaux, M. J. Tremblay, R. F. Omar, and M. G. Bergeron Sodium Lauryl Sulfate Abrogates Human Immunodeficiency Virus Infectivity by Affecting Viral Attachment Antimicrob. Agents Chemother., August 1, 2001; 45(8): 2229 - 2237. [Abstract] [Full Text] [PDF]

				S. Roy, P. Gourde, J. Piret, A. Désormeaux, J. Lamontagne, C. Haineault, R. F. Omar, and M. G. Bergeron Thermoreversible Gel Formulations Containing Sodium Lauryl Sulfate or n-Lauroylsarcosine as Potential Topical Microbicides against Sexually Transmitted Diseases Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1671 - 1681. [Abstract] [Full Text]

				Microbicides 2001: The Search for HIV Protection AIDS Clinical Care, March 1, 2001; 2001(301): 8 - 8. [Full Text]

				C Coggins, K Blanchard, F Alvarez, V Brache, E Weisberg, P H Kilmarx, M Lacarra, R Massai, D Mishell Jr, A Salvatierra, et al. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide Sex Transm Inf, December 1, 2000; 76(6): 480 - 483. [Abstract] [Full Text] [PDF]

				G. M. Wingood and R. J. DiClemente Application of the Theory of Gender and Power to Examine HIV-Related Exposures, Risk Factors, and Effective Interventions for Women Health Educ Behav, October 1, 2000; 27(5): 539 - 565. [Abstract] [PDF]

				N. Bourne, L. R. Stanberry, E. R. Kern, G. Holan, B. Matthews, and D. I. Bernstein Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2471 - 2474. [Abstract] [Full Text]

				A. A. Al-Jabri, M. D. Wigg, E. Elias, R. Lambkin, C. O. Mills, and J. S. Oxford In vitro anti-HIV-1 virucidal activity of tyrosine-conjugated tri- and dihydroxy bile salt derivatives J. Antimicrob. Chemother., May 1, 2000; 45(5): 617 - 621. [Abstract] [Full Text] [PDF]

				J. S. St. Lawrence, A. P. Chapdelaine, J. G. Devieux, R. E. O'Bannon III, T. L. Brasfield, and G. D. Eldridge Measuring Perceived Barriers to Condom Use: Psychometric Evaluation of the Condom Barriers Scale Assessment, December 1, 1999; 6(4): 391 - 404. [Abstract] [PDF]

				H. L. SURRATT, W. M. WECHSBERG, L. B. COTTLER, C. G. LEUKEFELD, H. KLEIN, and D. P. DESMOND Acceptability of the Female Condom Among Women at Risk for HIV Infection American Behavioral Scientist, May 1, 1998; 41(8): 1157 - 1170. [Abstract]

				E. Abel and I. Miller Sexual Risk Behaviors among Rural Women of Childbearing Age J Holist Nurs, September 1, 1997; 15(3): 282 - 302. [Abstract] [PDF]

				K. E. Nelson, D. D. Celentano, S. Eiumtrakol, D. R. Hoover, C. Beyrer, S. Suprasert, S. Kuntolbutra, and C. Khamboonruang Changes in Sexual Behavior and a Decline in HIV Infection among Young Men in Thailand N. Engl. J. Med., August 1, 1996; 335(5): 297 - 303. [Abstract] [Full Text] [PDF]

				F. Smyth and R. Thomas Preventative action and the diffusion of HIV/AIDS Progress in Human Geography, March 1, 1996; 20(1): 1 - 22. [PDF]

				S. L. Rosenthal, F. M. Biro, P. A. Succop, J. G. Baker, and L. R. Stanberry Reasons for Condom Utilization Among High-Risk Adolescent Girls Clinical Pediatrics, December 1, 1994; 33(12): 706 - 711. [Abstract] [PDF]

				S. C. Quinn AIDS and the African American Woman: The Triple Burden of Race, Class, and Gender Health Educ Behav, October 1, 1993; 20(3): 305 - 320. [Abstract] [PDF]

				N. K. Hansel, M. E. Weeks, J. G. Ryan, and G. C. Fowler The Female Role in the Transmission of HIV Infection Arch Fam Med, August 1, 1993; 2(8): 870 - 873. [Abstract] [PDF]

				N. L. Leland and R. P. Barth Characteristics of Adolescents Who Have Attempted to Avoid HIV and Who Have Communicated with Parents About Sex Journal of Adolescent Research, January 1, 1993; 8(1): 58 - 76. [Abstract]

				J. Kreiss, E. Ngugi, K. Holmes, J. Ndinya-Achola, P. Waiyaki, P. L. Roberts, I. Ruminjo, R. Sajabi, J. Kimata, T. R. Fleming, et al. Efficacy of Nonoxynol 9 Contraceptive Sponge Use in Preventing Heterosexual Acquisition of HIV in Nairobi Prostitutes JAMA, July 22, 1992; 268(4): 477 - 482. [Abstract] [PDF]

				M. E. Guinan HIV, Heterosexual Transmission, and Women JAMA, July 22, 1992; 268(4): 520 - 521. [Abstract] [PDF]